Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 (SmartGuard <TM>/MegametalliQ <TM>) to Reduce Blood Lead Levels in Young Women of Child-bearing Age (18 to 40 Years Old)

NCT05507021 is registered in ClinicalTrials.gov with Novozymes A/S as lead sponsor.

NCT NCT05507021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05507021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial to Evaluate the Efficacy and Safety of Lactobacillus Plantarum DSM 33464 (SmartGuard <TM>/MegametalliQ <TM>) to Reduce Blood Lead Levels in Young Women of Child-bearing Age (18 to 40 Years Old)
Lead sponsor
Novozymes A/S
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2022
Completion date
April 12, 2023
Enrollment
47 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elevated blood lead levels